The healthcare sector is a constant source of innovation and growth, and a vital component of this sector is the pharmaceutical market – which is expected to reach about $2.8 trillion by 2033, expanding at a compound annual growth rate of 6.2%. The market growth is driven by an increasingly ageing population, higher healthcare spending, biotech advancements, and the rise in lifestyle-related diseases. Novo Nordisk (NVO) shares are up roughly 22% on a YTD basis, surpassing the broader market. The Food and Drug Administration’s (FDA) expanded approval of its blockbuster weight-loss drug, Wegovy,…